The Systemic Cellular Immune Functions in Cardiomyopathy: Revisiting Approach
Journal of Clinical Immunology & Microbiology · 24.05.2026 · 7 (2) · 1-7
DOI: 10.46889/jcim.2026.7203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology & Microbiology, online erschienen am 24.05.2026. Verfasst von Ibrahim MS Shnawa und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
The cardiologist of the working team based onto clinical and laboratory evidences diagnose 23 cardiomyopathy cases at Mirgan Teaching Hospital-Babylon /Iraq. Whom complaining concurrent inflammatory infectious respiratory and/ or urinary disease in continuum with senescence. The objective of the present work was to investigate the systemic cellular immune functions in these cardiomyopathy patients. The test battery was including clinical tuberculin DTH skin test at strength of 2,5 and 20 IU20 tuberculin and Mcarophage inhibition factor cytokines against same tuberculin concentrations. Tuberculin responder patterns were as; non-responders, low, medium and high responders. Twelve out of the 23 were tuberculin allergic and eleven out of the 23 patients were skin tuberculin anergic. Five of the tuberculin anergic were boosted with BCG shot, one week latter, tuberculin ID injection have shown that no evidence for immune-conversion to tuberculin skin allergic state. MIF investigation has shown that both of the allergic and anergic patients presented nosignificant, boarderline and significant MIF cytokine percentages, a state indicating cellular immune divergence. The statistical correlation between tuberculin concentration and MIF % was of simple linear negative type as regression analysis indicated. Leukocyte irresponsiveness were traced to 2 IU tuberculin both in allergic and anergic patients. Taken together, cardiomyopathy patients were found tuberculin allergic and anergic. The anergic cases were non-convertible to allergic onto a week post to BCG booster shot. Both of the allergic and anergic cases showed divergent systemic cellular immune functions.
Zitieren
APA
Shnawa, I. M., MM, A., & BHH, A. (2026). The Systemic Cellular Immune Functions in Cardiomyopathy: Revisiting Approach. Journal of Clinical Immunology & Microbiology, 7(2), 1-7. https://doi.org/10.46889/jcim.2026.7203
Vancouver
Shnawa IM, MM A, BHH A. The Systemic Cellular Immune Functions in Cardiomyopathy: Revisiting Approach. Journal of Clinical Immunology & Microbiology. 2026;7(2):1-7. doi:10.46889/jcim.2026.7203
BibTeX
@article{Shnawa2026,
author = {Shnawa, Ibrahim MS and MM, Al-Shok and BHH, Alameidi},
title = {The Systemic Cellular Immune Functions in Cardiomyopathy: Revisiting Approach},
journal = {Journal of Clinical Immunology & Microbiology},
year = {2026},
volume = {7},
number = {2},
pages = {1--7},
doi = {10.46889/jcim.2026.7203}
}
EUVIMED